These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 16180119

  • 1. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.
    Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y.
    Pharm Res; 2005 Oct; 22(10):1627-33. PubMed ID: 16180119
    [Abstract] [Full Text] [Related]

  • 2. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice.
    Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y.
    J Control Release; 2005 Nov 28; 108(2-3):294-305. PubMed ID: 16209897
    [Abstract] [Full Text] [Related]

  • 3. Changes in immune responses to mite antigen sensitized through barrier-disrupted skin with CpG-oligodeoxynucleotide in mice.
    Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y.
    Biol Pharm Bull; 2006 Feb 28; 29(2):385-7. PubMed ID: 16462052
    [Abstract] [Full Text] [Related]

  • 4. Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic dermatitis.
    Inoue J, Aramaki Y.
    J Immunol; 2007 Jan 01; 178(1):584-91. PubMed ID: 17182599
    [Abstract] [Full Text] [Related]

  • 5. Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice.
    Takakura M, Takeshita F, Aihara M, Xin KQ, Ichino M, Okuda K, Ikezawa Z.
    J Invest Dermatol; 2005 Dec 01; 125(6):1156-62. PubMed ID: 16354185
    [Abstract] [Full Text] [Related]

  • 6. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
    Kim YS, Kim Y, Lee KJ, Kwon HJ, Kim DS, Kim TY.
    Int Arch Allergy Immunol; 2007 Dec 01; 144(4):315-24. PubMed ID: 17671391
    [Abstract] [Full Text] [Related]

  • 7. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
    Sugai T, Mori M, Nakazawa M, Ichino M, Naruto T, Kobayashi N, Kobayashi Y, Minami M, Yokota S.
    Vaccine; 2005 Nov 16; 23(46-47):5450-6. PubMed ID: 16006019
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral administration of CpG ODN-OVA on WBB6F1-W/Wv mice.
    Teshima R, Okunuki H, Sato Y, Akiyama H, Maitani T, Sawada J.
    Allergol Int; 2006 Mar 16; 55(1):43-8. PubMed ID: 17075285
    [Abstract] [Full Text] [Related]

  • 9. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
    Rattanakiat S, Nishikawa M, Takakura Y.
    Eur J Pharm Sci; 2012 Sep 29; 47(2):352-8. PubMed ID: 22771546
    [Abstract] [Full Text] [Related]

  • 10. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M, Hashemi M, Maleki M, Abnous K, Hashemitabar G, Ramezani M, Haghparast A.
    Int J Pharm; 2016 Dec 30; 515(1-2):708-720. PubMed ID: 27989827
    [Abstract] [Full Text] [Related]

  • 11. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
    Inoue J, Aramaki Y.
    Vaccine; 2007 Jan 22; 25(6):1007-13. PubMed ID: 17049678
    [Abstract] [Full Text] [Related]

  • 12. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A, Rutten V, Spiering R, van Kooten P, Willemse T, Broere F.
    Vet J; 2014 Apr 22; 200(1):103-8. PubMed ID: 24461202
    [Abstract] [Full Text] [Related]

  • 13. Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.
    Kitaoka M, Naritomi A, Hirakawa Y, Kamiya N, Goto M.
    Pharm Res; 2015 Apr 22; 32(4):1486-92. PubMed ID: 25361868
    [Abstract] [Full Text] [Related]

  • 14. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen.
    Yalcindag A, He R, Laouini D, Alenius H, Carroll M, Oettgen HC, Geha RS.
    J Allergy Clin Immunol; 2006 Jun 22; 117(6):1455-61. PubMed ID: 16751013
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
    Vasilakos JP, Smith RM, Gibson SJ, Lindh JM, Pederson LK, Reiter MJ, Smith MH, Tomai MA.
    Cell Immunol; 2000 Aug 25; 204(1):64-74. PubMed ID: 11006019
    [Abstract] [Full Text] [Related]

  • 16. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.
    Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, Saito T.
    Clin Exp Immunol; 2006 Jul 25; 145(1):130-8. PubMed ID: 16792683
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.